Asgard

Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology

Retrieved on: 
Thursday, March 14, 2024
Stem cell, Patient, Research, Factorization of polynomials, Science Immunology, POC, Publication, Asgard, Therapy, Immune system, Recreation, Investment, Pharmaceutical industry

The round was co-led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc., with participation from existing investors Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.

Key Points: 
  • The round was co-led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc., with participation from existing investors Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.
  • AT-108 is a first-in-class, off-the-shelf gene therapy that directly reprograms tumor cells into antigen-presenting dendritic cells, ultimately leading to a personalized anti-tumor immune response.
  • João Ribas, Principal, Novo Holdings, Seed Investments, said: "We're thrilled to welcome new investors JJDC and RV Invest to Asgard Therapeutics.
  • This marks a significant milestone for Asgard's novel concept of direct in vivo cellular reprogramming in oncology.

Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology

Retrieved on: 
Thursday, March 14, 2024
Stem cell, Patient, Research, Factorization of polynomials, Science Immunology, POC, Publication, Asgard, Therapy, Immune system, Recreation, Investment, Pharmaceutical industry

The round was co-led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc., with participation from existing investors Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.

Key Points: 
  • The round was co-led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc., with participation from existing investors Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.
  • AT-108 is a first-in-class, off-the-shelf gene therapy that directly reprograms tumor cells into antigen-presenting dendritic cells, ultimately leading to a personalized anti-tumor immune response.
  • João Ribas, Principal, Novo Holdings, Seed Investments, said: "We're thrilled to welcome new investors JJDC and RV Invest to Asgard Therapeutics.
  • This marks a significant milestone for Asgard's novel concept of direct in vivo cellular reprogramming in oncology.

Wolters Kluwer Expands CCH® Tagetik Corporate Performance Management Capabilities to Help Taiwan Companies Address ESG + Global Minimum Tax Requirements

Retrieved on: 
Thursday, May 11, 2023
Pillar, Global minimum corporate tax rate, Organization, Data, Face, Taiwan Stock Exchange, Economy, Disclosure, Wolters Kluwer, OECD, Maternity leave and the Organisation for Economic Co-operation and Development, CFOS, Ministry, Automation, Asgard, CPM, Growth, ESG, Ministry of Finance (Indonesia), Greater China, KPI-driven code analysis, Asset management, Online shopping, Renewable energy, Development

TAIPEI, Taiwan, May 11, 2023 /PRNewswire/ -- Wolters Kluwer, a global leader in professional information, software solutions, and services, today announced the expansion of its CCH® Tagetik Corporate Performance Management (CPM) portfolio in Taiwan – introducing new functionality to help Taiwan multinational companies address evolving Global Minimum Tax and ESG regulations.

Key Points: 
  • More than 1,700 global enterprises currently utilize the CCH Tagetik expert solution.
  • New CCH Tagetik functionality will support multinational Taiwan companies that will be impacted by new, Global Minimum Tax requirements, which the Ministry of Finance expects to adopt as early as 2024 for certain global enterprises.
  • Specifically, the CCH Tagetik Global Minimum Tax solution will empower enterprises collect, align, calculate and report integrated finance and tax data in compliance with Organisation for Economic Co-operation and Development (OECD) Pillar Two tax requirements.
  • New CCH Tagetik ESG & Sustainability Performance Management functionality helps companies comply with ESG reporting and disclosure requirements, while driving long-term, sustainable growth.

Hitachi Energy supplies world-breaking OceaniQ subsea transformers to OneSubsea for its subsea multiphase compression system

Retrieved on: 
Monday, July 11, 2022
Ormen Lange, Farm, Asgard, Industry, Automation, Operational technology, Harman Becker Automotive Systems, MVA, Ormen Lange (gas field), Corrosion, NYSE, OneSubsea, Shell, Digital Systems, Wind, ABB, History, Technology, Natural gas, SLB, Mobility, Growth, Efficiency, Robotics, Transformer, Renewable energy, Electric power industry, Nyhamna, Schlumberger

The transformers form part of a large contract awarded to Hitachi Energy for the supply of two subsea OceaniQTM transformers, two input transformers, two step-up transformers, and a common step-down distribution transformer.

Key Points: 
  • The transformers form part of a large contract awarded to Hitachi Energy for the supply of two subsea OceaniQTM transformers, two input transformers, two step-up transformers, and a common step-down distribution transformer.
  • The OneSubsea compression system will be powered and controlled from the Nyhamna onshore gas processing plant, which is 120 km from the subsea location.
  • "We are delighted to be collaborating with ABB and OneSubsea on this important project," said Bruno Melles, Head of the Transformer Business at Hitachi Energy.
  • Hitachi Energy's OceaniQ subsea transformer technology is also ideally suited for the connection of floating offshore wind farms to the grid.

VirnetX Zero Trust Technology Implemented by Neurofeedback Company, IASIS Technologies

Retrieved on: 
Tuesday, January 18, 2022
ZEPHYR, Zero, Sustainability, Voice over IP, VirnetX, PTSD, Technology, Private Securities Litigation Reform Act, UC, Asgard, Organization, NYSE, Boodle fight, Federation, Mental health, U.S. Securities and Exchange Commission, 2020 United States federal government data breach, VHC, United States Department of Veterans Affairs, Company, Corporation, Military personnel, Trust, LTE, Security (finance), University of California, San Diego, Cryptocurrency

ZEPHYR COVE, Nev., Jan. 18, 2022 /PRNewswire/ --VirnetX Holding Corporation (NYSE:VHC), an Internet security software and technology company, announced today that IASIS Technologies International ("IASIS"), a global leader in healing through neurofeedback technology, announced the implementation of Asgard's Zero-Trust EverSafe Backup and Disaster Recovery solution built on VirnetX's encrypted Zero Trust Networking Technology to support the critical nature of IASIS' operations and protect the electronic protected health information of its clients.

Key Points: 
  • ZEPHYR COVE, Nev., Jan. 18, 2022 /PRNewswire/ --VirnetX Holding Corporation (NYSE:VHC), an Internet security software and technology company, announced today that IASIS Technologies International ("IASIS"), a global leader in healing through neurofeedback technology, announced the implementation of Asgard's Zero-Trust EverSafe Backup and Disaster Recovery solution built on VirnetX's encrypted Zero Trust Networking Technology to support the critical nature of IASIS' operations and protect the electronic protected health information of its clients.
  • Additionally, zero trust security is now recommended by the Federal Government as a critical component of any security strategy with 76% of organizations in the process of implementing zero trust security.
  • "VirnetX Zero Trust Networking Technology enables EverSafe to improve upon Veeam Software's best in class backup and recovery platform with unparalleled levels of zero trust security delivering the most secure data protection available anywhere to our clients.We are singularly focused on our client's uptime availability and EverSafe with Virnetx Zero Trust Networking Technology achieves that," said Asgard Chief Executive OfficerBrian Waltermire.
  • VirnetX Holding Corporation is an Internet security software and technology company with patented technology for secure communications including 4G LTE and 5G security.

ASGARD DAO Launches a New Era in Decentralized Finance

Retrieved on: 
Friday, January 14, 2022
Treasury, LP, Asgard, BSC, Decentralized finance, Blockchain, Map, NFT, Dapp, Defi, Non-fungible token, Sale, Liquidity, Cryptocurrency, Bond

The purpose of Asgard is to develop a new asset class token that can be utilized in any portfolio.

Key Points: 
  • The purpose of Asgard is to develop a new asset class token that can be utilized in any portfolio.
  • To receive incentives with Asgard, customers would bet their $Asgard on the Asgard dApp website.
  • Bonds: Bonds are the process of exchanging Liquidity Provider (LP) tokens for discounted Asgard tokens that are below market price.
  • Asgard exemplifies the revolutionary potential of DeFi 2.0's capacity to tackle some of DeFi's most pressing issues.

Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics

Retrieved on: 
Tuesday, November 9, 2021
Novo Nordisk Foundation, Therapy, Regenerative medicine, Celebrity board director, Founder, European Commission, Entrepreneurship, Doctor of Philosophy, Technology, Vinnova, Seed, Cristiana, Framework Programmes for Research and Technological Development, Growth, Research, Lund University, Asgard, Cancer, Company, Novo Holdings A/S, EUR, Innovation, Representation of the European Commission in Germany, Cell, Novo Nordisk, Fine chemical, Pharmaceutical industry

COPENHAGEN, Denmark, Nov.9, 2021 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR 6 million seed financing in Asgard Therapeutics AB ("Asgard"), a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.

Key Points: 
  • COPENHAGEN, Denmark, Nov.9, 2021 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR 6 million seed financing in Asgard Therapeutics AB ("Asgard"), a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.
  • The financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.
  • As part of the transaction, Sren Mller (Novo Holdings), Philipp Mller (BIVF), Jonas Jendi (Industrifonden), and Filipe Pereira (Asgard Therapeutics) join as Board Directors, and Joo Ribas (Novo Holdings) and Fbio Rosa (Asgard Therapeutics) as Board Observers.
  • Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.

Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics

Retrieved on: 
Tuesday, November 9, 2021
Novo Nordisk Foundation, Therapy, Regenerative medicine, Celebrity board director, Founder, European Commission, Entrepreneurship, Doctor of Philosophy, Technology, Vinnova, Seed, Cristiana, Framework Programmes for Research and Technological Development, Growth, Research, Lund University, Asgard, Cancer, Company, Novo Holdings A/S, EUR, Innovation, Representation of the European Commission in Germany, Cell, Novo Nordisk, Fine chemical, Pharmaceutical industry

COPENHAGEN, Denmark, Nov. 9, 2021 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR 6 million seed financing in Asgard Therapeutics AB ("Asgard"), a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.

Key Points: 
  • COPENHAGEN, Denmark, Nov.9, 2021 /PRNewswire/ -- Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR 6 million seed financing in Asgard Therapeutics AB ("Asgard"), a private biotech company pioneering in vivo direct cell reprogramming approaches to elicit potent anti-cancer immune responses.
  • The financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden.
  • As part of the transaction, Sren Mller (Novo Holdings), Philipp Mller (BIVF), Jonas Jendi (Industrifonden), and Filipe Pereira (Asgard Therapeutics) join as Board Directors, and Joo Ribas (Novo Holdings) and Fbio Rosa (Asgard Therapeutics) as Board Observers.
  • Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.

Fair Go Casino Player Walks Away $41,400 Richer

Retrieved on: 
Wednesday, November 3, 2021
Casino, Gaming, Entertainment, Mobile Entertainment, Diamond, Bitcoin, Fair Go, Mastercard, Camping, Visa, Sweet Sixteen, Asgard, Amusement arcade, Online gambling

Proving that Asgard really is the home of legends, Melbourne resident, Caroline Gassen, hit the games jackpot at Fair Go Casino , walking away with a $41,400 win in her pocket.

Key Points: 
  • Proving that Asgard really is the home of legends, Melbourne resident, Caroline Gassen, hit the games jackpot at Fair Go Casino , walking away with a $41,400 win in her pocket.
  • Fair Go player Pauline Mateo was on a camping trip in west Australia when she decided to try Fair Go for the first time and hit a $4,000 epic spin on Diamond Fiesta.
  • Rebecca Ryder, Fair Go Casino Manager, said: To see so many players in so many different places winning big at Fair Go makes us very happy.
  • Fair Go Casino is available on desktop and mobile and offers a wide range of payment methods including Visa, MasterCard, Neosurf and Bitcoin.

VirnetX Zero Trust Networking Technology Implemented by Credit Union Advisor for Ransomware Protection

Retrieved on: 
Tuesday, October 26, 2021
ZEPHYR, Zero, Corporation, 3GPP, Organization, Credit union, Security (finance), Boodle fight, U.S. Securities and Exchange Commission, Adoption, Private Securities Litigation Reform Act, Trust, NYSE, LTE, Voice over IP, VirnetX, Asgard, Veeam, SAE, VHC, Intelligence, Technology, Risk, Company, Patent, National Credit Union Administration, Online shopping, Risk management

ZEPHYR COVE, Nev., Oct. 26, 2021 /PRNewswire/ -- VirnetX Holding Corporation (NYSE: VHC), an Internet security software and technology company, announced today that the National Credit Union ISAO ("NCU-ISAO"), enhancing Credit Union cyber resilience through information sharing, intelligence, operational guidance, and workforce education, has implemented VirnetX's Zero Trust Networking Technology with Asgard's Zero-Trust EverSafe Backup and Disaster Recovery Service for ransomware protection.

Key Points: 
  • ZEPHYR COVE, Nev., Oct. 26, 2021 /PRNewswire/ -- VirnetX Holding Corporation (NYSE: VHC), an Internet security software and technology company, announced today that the National Credit Union ISAO ("NCU-ISAO"), enhancing Credit Union cyber resilience through information sharing, intelligence, operational guidance, and workforce education, has implemented VirnetX's Zero Trust Networking Technology with Asgard's Zero-Trust EverSafe Backup and Disaster Recovery Service for ransomware protection.
  • Additionally, zero trust security is now recognized as a critical component of any security strategy with 76% of organizations in the process of implementing zero trust security.
  • "We believe in VirnetX's Zero Trust Networking Technology and were interested to learn more about how Asgard's EverSafe solution could leverage it to create a safe, zero trust backup solution," said Brian Hinze, NCU-ISAO Director and Vice President.
  • "VirnetX Zero Trust Networking Technology enables EverSafe to improve upon Veeam's best in class backup and recovery platform with unparalleled zero trust security delivering the most secure data protection available anywhere to our clients," said Asgard Chief Executive Officer Brian Waltermire.